Brief

Based on the provided text, I will attempt to provide a response in the format you requested.

5.17 Any other information (optional)

Please provide any additional information that you believe is relevant to your proposal. This may include, but is not limited to:

  • Additional study protocols or documents
  • Supporting data or references
  • Further explanations or clarifications on any points mentioned above

References

  1. New Drugs and Clinical Trials Rules, 2019 under Drugs and Cosmetics Act, 1940.
  2. GCP guidelines published by CDSCO, DGHS, Govt. of India.
  3. Ethical Guidelines for Biomedical Research on Human Subjects published by Indian Council of Medical Research, New Delhi.

Please let me know if this meets your requirements or if you need further assistance!

Hello!

To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.

Go to Home Page

Highlights content goes here...

Hello!

To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.

Go to Home Page

Central Drugs Standard Control Organization (CDSCO)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies